slides · global inventory
Cite Precedent
Slide function collection for the active corpus filters, with each row opening the slide detail view.
Matching slides 2,146
Current window 1,681-1,710
Pages 72
Rows per page 30
Slide function
1,681-1,710 of 2,146
50
The slide uses a timeline-based comparison to suggest that Spyre's assets are on a similar trajectory to high-value acquired assets.Aeglea BioTherapeutics | Investor Presentation Deck | 56 slides · Aeglea BioTherapeutics
Pitch deck Investor relations Beat · Action1 hit
52
The slide serves as a credibility transfer by showcasing the partner's team and achievements.Aeglea BioTherapeutics | Investor Presentation Deck | 56 slides · Aeglea BioTherapeutics
Pitch deck Investor relations Beat · Action1 hit
11
The Venn diagram shows the intersection of genetic targets (TL1A, IL-23, a4b7). The bar chart compares 'All-comers' vs 'CDx+' (companion diagnostic positive) patient groups for two drugs (PRA023 and RVT-3101).Aeglea BioTherapeutics | Mergers and Acquisitions Presentation Deck | 50 slides · Aeglea BioTherapeutics
Deck Investment bank Beat · Solution & ApproachLoop · Golden Circle1 hit
14
Alkermes | Investor Presentation Deck | 56 slidesAlkermes | Investor Presentation Deck | 56 slides · Alkermes
Conference presentation Investor relations Beat · Evidence & Proof1 hit
15
Includes a quote from a Bayer executive regarding the collaboration.Dare Bioscience | Investor Presentation Deck | 26 slides · Daré Bioscience
Pitch deck Investor relations 1 hit
09
This slide outlines regulatory requirements for clinical trial design, including placebo run-in periods, patient population definition, PRO instruments, and primary endpoints.Dare Bioscience | Investor Presentation Deck | 27 slides · Daré Bioscience
Pitch deck Investor relations Beat · Problem (Identify pain)Loop · Cost Of Inaction1 hit
11
Enochian Biosciences | Results Presentation Deck | 43 slidesEnochian Biosciences | Results Presentation Deck | 43 slides · Renovaro Biosciences
Pitch deck Investor relations 1 hit
13
The slide uses a quote from a subject matter expert to build credibility.Enochian Biosciences | Results Presentation Deck | 43 slides · Renovaro Biosciences
Pitch deck Investor relations 1 hit
37
The slide uses a quote from a key advisor to validate the scientific potential of the company's technology beyond its primary cancer focus.Enochian Biosciences | Results Presentation Deck | 43 slides · Renovaro Biosciences
Pitch deck Investor relations Beat · Impact & Next Steps1 hit
19
The slide outlines two main pillars of the collaboration: targeted alpha therapies and combination therapies.Fusion Pharmaceuticals | Investor Presentation Deck | 33 slides · Fusion Pharmaceuticals
Pitch deck Investor relations 1 hit
30
The slide uses a 'build-up' logic to contrast the consolidation of the market with the unique position of the company.Grove | Investor Presentation Deck | 41 slides · Grove Collaborative
Pitch deck Investor relations Beat · Ultimate Achievement1 hit
07
The slide uses a split-layout with testimonials on the left and research summaries on the right.Hyperfine | Investor Presentation Deck | 16 slides · Hyperfine
Pitch deck Investor relations 1 hit
15
The slide uses a checklist-style layout to map acquisition criteria to specific strategic outcomes.Limbach Holdings | Investor Presentation Deck | 26 slides · Limbach
Pitch deck Investor relations 1 hit
17
The slide outlines the strategic fit of the Acme Industrial acquisition for Limbach, including financial metrics and operational synergies.Limbach Holdings | Investor Presentation Deck | 27 slides · Limbach
Pitch deck Investor relations 1 hit
08
The slide uses USPSTF clinical guidelines to establish the market/clinical importance of anxiety screening.MindMed | Investor Day Presentation Deck | 61 slides · MindMed
Conference presentation Investor relations Beat · Market Size1 hit
38
MindMed | Investor Day Presentation Deck | 61 slidesMindMed | Investor Day Presentation Deck | 61 slides · MindMed
Conference presentation Investor relations 1 hit
52
MindMed | Investor Day Presentation Deck | 61 slidesMindMed | Investor Day Presentation Deck | 61 slides · MindMed
Conference presentation Investor relations 1 hit
12
The slide uses a table to establish clinical credibility by citing historical and modern research.MindMed | Investor Presentation Deck | 32 slides · MindMed
Pitch deck Investor relations 1 hit
30
The slide uses a logo-grid to establish credibility through past professional achievements.MindMed | Investor Presentation Deck | 32 slides · MindMed
Pitch deck Investor relations 1 hit
07
The slide uses a case study to validate the business/clinical model of combination therapies.NeuroSense Therapeutics | Investor Presentation Deck | 34 slides · NeuroSense Therapeutics
Pitch deck Investor relations Beat · SolutionLoop · Jobs To Be Done1 hit
21
The slide uses a logo-grid layout to establish credibility through institutional and industry partnerships.NeuroSense Therapeutics | Investor Presentation Deck | 34 slides · NeuroSense Therapeutics
Pitch deck Investor relations Beat · SolutionLoop · Jobs To Be Done1 hit
06
Uses a hub-and-spoke layout to attribute multiple critical statements to the ISS report.Sarissa Capital | Activist Presentation Deck | 17 slides · Sarissa Capital
Activist deck Activist investor Beat · Cite PrecedentLoop · Golden Circle1 hit
07
Uses a cartoon illustration to represent the 'Shareholder Capital' perspective in a boardroom setting.Sarissa Capital | Activist Presentation Deck | 17 slides · Sarissa Capital
Activist deck Activist investor Beat · Cite PrecedentLoop · Golden Circle1 hit
09
Uses authority citation to validate the activist's nominee.Sarissa Capital | Activist Presentation Deck | 17 slides · Sarissa Capital
Activist deck Activist investor Loop · Golden Circle1 hit
11
The spinning tops are likely a visual metaphor for the 'spin-out' of the oncology business.Sarissa Capital | Activist Presentation Deck | 17 slides · Sarissa Capital
Activist deck Activist investor 1 hit
15
Uses a 'before-after' or 'thesis-execution' comparison structure to validate the activist's track record.Sarissa Capital | Activist Presentation Deck | 36 slides · Sarissa Capital
Activist deck Activist investor Beat · The Struggle1 hit
16
Includes a cartoon illustration of a person with a headache to emphasize the 'headache' metaphor used in the text.Sarissa Capital | Activist Presentation Deck | 36 slides · Sarissa Capital
Activist deck Activist investor Beat · The Struggle1 hit
06
The slide uses a series of company logos and acquisition metrics to establish credibility.Sarissa Capital | Activist Presentation Deck | 95 slides · Sarissa Capital
Activist deck Activist investor Beat · Expose ContradictionLoop · Logic Chain1 hit
71
Uses a press release excerpt as a case study for corporate restructuring.Sarissa Capital | Activist Presentation Deck | 95 slides · Sarissa Capital
Activist deck Activist investor Beat · Expose ContradictionLoop · Mece Breakdown1 hit
06
The slide uses a horizontal bar chart/timeline hybrid to illustrate market entry timing.Sonos | Investor Presentation Deck | 20 slides · Sonos
Pitch deck Investor relations Beat · Rising Success1 hit